Mallinckrodt plc
Mallinckrodt plc (MNK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MNK · as of Jun 9, 2026
Key Statistics
Explore Mallinckrodt plc Data
mnk stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 33 · Buy rate: 21.2%
Competitors & Peers
mnk competitorsMNK
APTO
BVXV
GMDA
HILS
MDGSStock Performance
Full HistoryAbout Mallinckrodt plc
Mallinckrodt plc operates as a global pharmaceutical company, engaged in the development, manufacturing, marketing, and distribution of specialized medical products and therapies. Its extensive reach …
what is mallinckrodt plc · mnk stock overview · mallinckrodt plc company profile · who is mallinckrodt plc ceo · mnk AMEX · mallinckrodt plc headquarters · mallinckrodt plc business segments
About Stock Overview & Key Data
Mallinckrodt plc (MNK) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on AMEX since Jun 21, 2022. As of the latest trading session, MNK stock price is $0.34, with a market capitalization of $4.5M. The stock has returned -97.80% over the past 12 months and -95.62% year-to-date.
According to 33 Wall Street analysts, the consensus rating for Mallinckrodt plc stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Mallinckrodt plc reported revenue of $1.4B and net income of -$489.5M. For detailed data — including Mallinckrodt plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Mallinckrodt plc (MNK) stock price is $0.34. The stock is traded on AMEX under the ticker symbol MNK. The 52-week range is $0.30 – $16.00.